Metraipolis › archive › dc_bdf94f555265

Protein lactylation: a metabolic signal driving cancer therapy resistance — Europe PMC PMID:41916971

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41916971
DOI
10.1038/s41420-[numero omesso]-w
License (as archived)
solo-consultazione
Archived
2026-11-03T14:36:56.425Z
SHA-256 of the archived text
4eb3505666d5074568b72b59c63db0c286d9411b7ea32b5c69aa223c53a68b46
Stable URL of this page
https://metraipolis.com/documento/dc_bdf94f555265

How to cite

Protein lactylation: a metabolic signal driving cancer therapy resistance — Europe PMC PMID:41916971 — Europe PMC (en), https://europepmc.org/article/MED/41916971 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_bdf94f555265 (Metraipolis archive dc_bdf94f555265, sha256 4eb3505666d5074568b72b59c63db0c286d9411b7ea32b5c69aa223c53a68b46)
BibTeX
@misc{dcbdf94f555265,
  title = {Protein lactylation: a metabolic signal driving cancer therapy resistance — Europe PMC PMID:41916971},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41916971},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_bdf94f555265; sha256 4eb3505666d5074568b72b59c63db0c286d9411b7ea32b5c69aa223c53a68b46},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41916971. Agents can read the archived copy with the MCP tool read_document.